A strategic approach to regulating new antimicrobials

Area of Science:

• Public Health
• Infectious Diseases
• Pharmacology

Background:

• Antimicrobial resistance (AMR) poses a significant threat to healthcare in India, with increasing resistance to critical and last-resort antibiotics.
• Rising resistance limits treatment options for drug-resistant infections, necessitating urgent strategies for antimicrobial preservation.

Purpose of the Study:

• To propose a regulatory and access framework to preserve and extend the longevity of new antimicrobials in India.
• To address the challenges in enforcing existing regulatory initiatives and inform future national-level strategies.

Main Methods:

• Review of emerging data on antimicrobial resistance trends in India.
• Analysis of historical patterns of antimicrobial resistance development.
• Examination of stakeholder perspectives on policy measures for responsible antimicrobial introduction.

Main Results:

• Resistance to last-resort antibiotics is increasing, limiting therapeutic options.
• Challenges exist in enforcing regulatory initiatives like Schedule H1 restrictions.
• A strategic national-level approach is needed for introducing new antimicrobials.

Conclusions:

• A proposed framework recommends restricting new antimicrobial access to hospitals with established antimicrobial stewardship and infection control programs.
• Mandatory antimicrobial resistance surveillance reporting is a key recommendation.
• Stakeholder engagement is crucial for developing effective policies for responsible antimicrobial introduction to combat rising AMR.